Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial

Achim Rittmeyer, Fabrice Barlési, Daniel Waterkamp et al. · The Lancet · 2016

Cited by 4,675 works. doi:10.1016/s0140-6736(16)32517-x Open-access PDF

Authors

References